TRIUS THERAPEUTICS

Trius Therapeutics is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. We have successfully completed two Phase 3 clinical trials for Tedizolid Phosphate (TR-701), formerly torezolid phosphate, in ABSSSI. Tedizolid is an IV and orally administered second generation oxazolidinone, for the treatment of serious gram-positive bacterial infections, including those caused by methicillin-resistant Staph... ylococcus aureus (MRSA). With the continuous increase in bacterial resistance to currently marketed drugs, serious infections are becoming more difficult, if not impossible to treat, and this has led to a clear need for novel therapeutics to treat multi-drug resistant bacterial infections. Trius is headquartered in San Diego, California. We have built a strong management team with significant development and regulatory experience. Our senior management team consists of nine individuals who collectively have been involved in the development and approval of a significant number of anti-infective drugs.

#SimilarOrganizations #People #Financial #Website #More

TRIUS THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Health Care

Founded:

2004-01-01

Address:

Lexington, Massachusetts, United States

Country:

United States

Website Url:

http://www.triusrx.com

Total Employee:

1001+

Status:

Closed

Contact:

8586779975

Total Funding:

69.33 M USD

Technology used in webpage:

Domain Not Resolving Euro Cloudflare DNS WorldStream

Similar Organizations

sorrento-therapeutics-logo

Sorrento Therapeutics

Sorrento Therapeutics is focused on the development of proprietary drug therapeutics for addressing unmet medical needs.

Current Advisors List

brian-atwood_image

Brian Atwood Board Member @ Trius Therapeutics
Board_member

david-kabakoff_image

David Kabakoff Chairman of the Board of Directors @ Trius Therapeutics
Board_member

Current Employees Featured

not_available_image

Craig Thompson
Craig Thompson Chief Commercial Officer @ Trius Therapeutics
Chief Commercial Officer

jeffrey-stein_image

Jeffrey Stein
Jeffrey Stein President & Chief Executive Officer @ Trius Therapeutics
President & Chief Executive Officer

Founder

john-schmid_image

John Schmid

Stock Details

Company's stock symbol is NASDAQ:TSRX

Investors List

versant-ventures_image

Official Site Inspections

http://www.triusrx.com

Host Informations
Whois Informations

Unable to get host informations!!!

Loading ...